Organizational Daily Notebook

From 2008.igem.org

(Difference between revisions)
(BRAINSTORMING)
Line 10: Line 10:
|}
|}
-
==[['''BRAINSTORMING''']]==
+
==[[BRAINSTORMING]]==
-
= Expression of a p1025-containing peptide in E. coli =
 
-
 
-
== References ==
 
-
PMID 9920267<br style="clear:both;"/>
 
-
A synthetic peptide adhesion epitope as a novel antimicrobial agent.<br style="clear:both;"/>
 
-
 
-
PMID 12536251<br style="clear:both;"/>
 
-
Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems.<br style="clear:both;"/>
 
-
 
-
== Materials ==
 
-
* The entire transcription unit will include
 
-
# T7 promoter for over-expression (IPTG inducible)
 
-
# ribosomal binding site
 
-
# secretion signal (~30AAs) for L. bulgaricus; whether or not it works in E. coli is not critical
 
-
# 1st epitope with spacer(~10AAs)
 
-
# p1025 peptide (20AAs)
 
-
# spacer and 2nd epitope (~10AAs)
 
-
# a protease cleavage site (target sequence of thrombin or TEV) plus a Gly and Ser rich flexible linker (~20AAs total). 
 
-
# GFP (~230AAs)
 
-
# 6xHis tag for affinity purification and on-column digestion with the protease, if necessary
 
-
# double STOP codon
 
-
# transcription terminator
 
-
 
-
= Adhesion of Streptococcus mutans to hydroxyapatite (HA) =
 
-
 
-
== Reference ==
 
-
PMID 9062560<br style="clear:both;"/>
 
-
Inhibition of Streptococcus mutans adsorption to hydroxyapatite by low-molecular-weight chitosans.<br style="clear:both;"/>
 
-
 
-
The materials and methods section describes an indirect plating assay to quantify binding of S. mutans to HA. Results in Table 1 indicates that this method can be used to quantify inhibition of binding by a competitor molecule.  In their study, the molecules are sugar polymers.<br style="clear:both;"/>
 
-
 
-
== Materials ==
 
-
* HA beads (from Fluka, 80-200 micro-meter grain size)
 
-
* saliva as source of the glyco-protein (one vendor is found through Google)
 
-
* S. mutans  and handling protocol (Chia is contacting Daniel Smith and Martin Taubman of the Forsyth Institute to acquire a suitable strain. Materials and methods section in the reference has a brief description on how to grow S. mutans.)
 
-
* synthetic p1025 and p1125 as positive and negative controls?
 
-
 
-
= Secretion of a p1025-containing peptide from Lactobacillus bulgaricus/lactis =
 
-
 
-
== References ==
 
-
 
-
PMID 12788739 (a secretion signal sequence described; can use the promoter, RBS and secretion signal for this protein for p1025)<br style="clear:both;"/>
 
-
Determination of the domain of the Lactobacillus delbrueckii subsp. bulgaricus cell surface proteinase PrtB involved in attachment to the cell wall after heterologous expression of the prtB gene in Lactococcus lactis.<br style="clear:both;"/>
 
-
 
-
PMID 11772607<br style="clear:both;"/>
 
-
Electrotransformation of Lactobacillus delbrueckii subsp. bulgaricus and L. delbrueckii subsp. lactis with various plasmids.
 
-
 
-
== Materials ==
 
-
* Lactobacillus bulgaricus or lactis (check with Tom Knight first.  Otherwise request from another lab or purchase from ATCC)
 
-
* growth medium: Ligia recommends the MRS medium. It can be purchased from Difco or Oxoid http://www.oxoid.com/uk/blue/index.asp
 
-
* Gas Pak to create an anaerobic/micro-aerobic environment. (Chia's lab can lend a few boxes and bags as anaerobic chambers. We can then purchase the disposable chemical envelopes known as "Gas Paks" that reduce oxygen content in a closed system.)
 
-
* Expression vector: [http://partsregistry.org/wiki/index.php/Part:BBa_I742103 BBa_I742103] in registry is a shuttle vector for E. coli and Lactobacillus. Let's look up this vector to see whether people have used it for protein expression. Alternatively we can get some of the plasmids described in PMID 11772607.
 
-
 
-
=Project road map=
 
-
[[Image:System_diagram_pic.jpg]]
 
-
==Stage 1==
 
-
 
-
*Construct parts for E. coli for production of the p1025 fusion peptide. Obtain antibodies against epitopes and maybe p1025 itself.
 
-
 
-
*Get the hydroxyapatite(HA)-S. mutans binding assay to work in our hands. 
 
-
 
-
*Practice growing and transformation of Lactobacillus. Design parts for Lactobacillus.
 
-
 
-
 
-
==Stage 2==
 
-
*Make E. coli produce the p1025 fusion peptide.
 
-
 
-
*(GOAL #1) See if the p1025 fusion peptide from E. coli can inhibit binding of S. mutants to HA beads.  Remove GFP if necessary.
 
-
 
-
*Engineer Lactobacillus
 
-
 
-
==Stage 3==
 
-
*(GOAL #2) Verify production and secretion of p1025 fusion peptide by Lactobacillus by Western (and/or microscopy if we decide to have a GFP-containing part in parallel).
 
-
*(GOAL #3) Can the yogurt reduce binding of S. mutans?
 
-
 
-
= Fundrai$ing! =
 
-
Drew has said that he can get in touch with some MIT alumni and the MIT development office.  We can send them the brochure and a letter to explain our goal, project and budget.
 
==JUN 10==
==JUN 10==

Revision as of 17:15, 24 June 2008


Home The Team The Project Parts Submitted to the Registry Modeling Notebook

Contents

BRAINSTORMING

JUN 10

File:System diagram pic.jpg

JUN 16

Summary of individual tasks to research:

  1. S. Mutans metabolism pathway-Asad
  2. L. bulgaricus metabolism pathway-Allin
  3. secretion (full or partial)-John
  4. other secretion systems (introduction of)-Sara
  5. T7 as a promoter (L. bulgaricus)-Prarthna
  6. L. bulgaricus transformation/protocols-Derek
  7. binding assay protocols-Andrew

Linear Sequence/Design

Ex-promoter-RBS-ATG-signal-epitope-p1025-linker (TEV cleavage site)-GFP-His-TAATAA-termination-SP (see top of page)

  • Base pairs: 35-10-3-90-30-60-45-700-15-6-8
  • potential eptiopes
    • FLAG (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys)
    • C-myc (E Q K L I S E E D L)
    • HA (Y P Y D U P D Y A: #2)

DNA/Plasmid Editor

Peptide Sequence Manipulations

Primer Analyzer Tool (check temperature & GC content)

  1. primers should be 17-28 bases in length;
  2. base composition should be 50-60% (G+C);
  3. primers should end (3') in a G or C, or CG or GC: this prevents "breathing" of ends and increases efficiency of priming;
  4. Tms between 55-80oC are preferred;
  5. 3'-ends of primers should not be complementary (ie. base pair), as otherwise primer dimers will be synthesised preferentially to any other product;
  6. primer self-complementarity (ability to form 2o structures such as hairpins) should be avoided;
  7. runs of three or more Cs or Gs at the 3'-ends of primers may promote mispriming at G or C-rich sequences (because of stability of annealing), and should be avoided.

Parts/Construction

  1. Construction
    1. GFP
    2. Synthetic peptide
    3. L. bulgaricus vector
  2. Assay
  3. L. bulgaricus
  4. S. Mutans

To Do/To Buy:

  • finalize DNA sequence
  • primer
  • synthesis
  • reagents

TEV Protease cut site

  • Amino Acid Sequence : Glu-Asn-Leu-Tyr-Phe-Gln-Gly (Cuts between Gln-Gly)
  • Base Pair Sequence: GAAAACCTGTACTTCCAGGGT


JUN 17

Links to sites from individual research topics

P4 Revised

File:P4-4.jpg

    • reverse sequence: CTG CAG CGG CCG CTA CTA GTA AGA GAA TAT AAA AAG CCA GAT TAT TAA TCC GGC TTT TTT ATT ATT TTT ATT AGT GGT GAT GGT GAT GAT GTT TGT ATA GTT CAT CCA TGC
    • length = 111 bp
    • melting temp = 69.6 C
    • GC content % = 36.0

JUN 18

  • [[../lbulgaricus |Lactobacillus delbrueckii subsp. bulgaricus Information & Protocols]]
  • [[../toothbindingassay | Tooth binding assay protocol]]

Friday Meeting breakdown

  1. Andrew: primers
  2. Derek: L. bulgaricus procedures
  3. Allin: metabolism
  4. John: binding assay
  5. Sara: secretion
  6. Asad: S. Mutans/Binding Assay
  7. Prarthna: promoters




Home The Team The Project Parts Submitted to the Registry Modeling Notebook